Compare MAPS & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MAPS | DRIO |
|---|---|---|
| Founded | 2008 | 2011 |
| Country | United States | United States |
| Employees | 449 | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.5M | 60.6M |
| IPO Year | N/A | 2013 |
| Metric | MAPS | DRIO |
|---|---|---|
| Price | $0.36 | $7.70 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $2.61 | ★ $35.00 |
| AVG Volume (30 Days) | ★ 7.7M | 6.0K |
| Earning Date | 05-11-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1559.02 |
| EPS | N/A | ★ 1.25 |
| Revenue | N/A | ★ $7,394,000.00 |
| Revenue This Year | N/A | $20.27 |
| Revenue Next Year | $6.17 | $47.58 |
| P/E Ratio | $9.75 | ★ $6.18 |
| Revenue Growth | N/A | ★ 43.02 |
| 52 Week Low | $0.32 | $0.38 |
| 52 Week High | $1.36 | $17.74 |
| Indicator | MAPS | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 33.93 | 47.67 |
| Support Level | $0.33 | $7.29 |
| Resistance Level | $0.75 | $9.46 |
| Average True Range (ATR) | 0.05 | 0.47 |
| MACD | -0.00 | -0.04 |
| Stochastic Oscillator | 12.23 | 30.43 |
WM Technology Inc operates an online cannabis marketplace for consumers, together with a comprehensive set of e-commerce and compliance software solutions for cannabis businesses, which are sold to both storefront locations and delivery operators (retailers) and brands in the legalized cannabis markets in states and territories of the United States. Its comprehensive business-to-consumer and business-to-business suite of products affords cannabis retailers and brands of all sizes integrated tools to compliantly run their businesses and to reach, convert, and retain consumers.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.